PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-8.49%
Both yoy net incomes decline, with ZETA at -19.40%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
8.84%
D&A growth well above ZETA's 4.30%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
103.07%
Well above ZETA's 92.33% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
11.46%
SBC growth well above ZETA's 11.66%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-275.14%
Both reduce yoy usage, with ZETA at -141.56%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-152.86%
Both yoy AR lines negative, with ZETA at -249.49%. Martin Whitman would suspect an overall sector lean approach or softer demand.
150.71%
Inventory growth of 150.71% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
149.89%
Lower AP growth vs. ZETA's 967.15%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
-22.65%
Both reduce yoy usage, with ZETA at -156.76%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
15.66%
Well above ZETA's 19.51%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-40.99%
Both yoy CFO lines are negative, with ZETA at -30.76%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-0.95%
Negative yoy CapEx while ZETA is 20.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
29.52%
Less M&A spending yoy vs. ZETA's 100.00%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
75.70%
Purchases growth of 75.70% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-43.78%
We reduce yoy sales while ZETA is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
78.66%
Growth of 78.66% while ZETA is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
64.28%
Investing outflow well above ZETA's 56.35%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment growth of 100.00% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-52.45%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
3.27%
Buyback growth of 3.27% while ZETA is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.